Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CFO David Mountcastle sold 5,566 shares of the firm's stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $20.85, for a total transaction of $116,051.10. Following the completion of the transaction, the chief financial officer directly owned 214,847 shares of the company's stock, valued at approximately $4,479,559.95. This trade represents a 2.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
David Mountcastle also recently made the following trade(s):
- On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01.
- On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total value of $141,278.80.
- On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The shares were sold at an average price of $21.90, for a total value of $141,320.70.
- On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total value of $133,134.36.
- On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total value of $119,847.55.
- On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total value of $134,025.00.
- On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total value of $192,809.85.
Privia Health Group Stock Up 1.8%
PRVA stock opened at $21.59 on Tuesday. The business has a 50 day moving average price of $22.09 and a two-hundred day moving average price of $23.42. The company has a market cap of $2.67 billion, a price-to-earnings ratio of 127.00, a P/E/G ratio of 1.32 and a beta of 0.87. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.21. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The company had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. During the same quarter last year, the firm posted $0.21 EPS. The company's quarterly revenue was up 17.4% on a year-over-year basis. On average, equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. Jefferies Financial Group reissued a "buy" rating and issued a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, February 26th. Royal Bank Of Canada initiated coverage on Privia Health Group in a research note on Friday, January 9th. They set an "outperform" rating and a $31.00 target price for the company. Truist Financial lifted their target price on Privia Health Group from $31.00 to $33.00 and gave the stock a "buy" rating in a research note on Monday, March 2nd. Weiss Ratings reiterated a "hold (c)" rating on shares of Privia Health Group in a research note on Friday, March 27th. Finally, Citigroup reduced their target price on Privia Health Group from $34.00 to $32.00 and set a "buy" rating for the company in a research note on Tuesday, March 3rd. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $31.13.
Get Our Latest Report on Privia Health Group
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bayban acquired a new position in Privia Health Group in the 4th quarter valued at $26,000. Hantz Financial Services Inc. grew its holdings in Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company's stock valued at $27,000 after buying an additional 926 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock valued at $38,000 after purchasing an additional 1,351 shares during the period. Canada Pension Plan Investment Board boosted its holdings in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock valued at $85,000 after purchasing an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in Privia Health Group in the 4th quarter valued at about $93,000. 94.48% of the stock is owned by institutional investors and hedge funds.
Privia Health Group Company Profile
(
Get Free Report)
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
